Home
 /
Papers
 /
Genomics
 /
Mouse Single-Cell Long-Read Splicing Atlas by Ouro-Seq
Preprint
Open access
V1
Top 1% · Validated by QED

Mouse Single-Cell Long-Read Splicing Atlas by Ouro-Seq

Hyunsu An, Sin Young Choi, Jawoon Yi +5 more
September 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.01.17.633678
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Genomics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By solving the length-bias artifact problem that crippled single-cell long-read sequencing and profiling 103,000 cells across 12 organs, Ouro-Seq delivers the first whole-organism isoform atlas, revealing cell-type-specific splicing programs invisible to short-read methods.

QED claims analysis

Summary

Ouro-Seq, a novel long-read single-cell RNA-sequencing framework that removes reverse transcription artifacts without length bias and normalizes mRNA size distributions, enables construction of a comprehensive mouse single-cell splicing atlas across 215 cell types from 12 organs that reveals extensive cell-type-specific usage of functionally distinct mRNA isoforms, uncovering previously unappreciated functional heterogeneity including exclusive expression of distinct Slc12a1 isoforms by different thick ascending limb cell populations and novel cell-type-specific promoters.

See full analysis
Main Claim 1 –

Selective self-cyclization depletes barcode-free and -doublet artifacts unbiasedly

Supporting evidence

  • Ouro-Seq minimizes barcode-doublet artifacts versus PCR/biotin methods
  • CRISPR-based Ouro-Enrich enables >20-fold transcript and cell enrichment
Main Claim 2 –

Ouro-Tools calls full-length cDNAs and normalizes mRNA lengths

Main Claim 3 –

Mouse single-cell long-read atlas maps splicing, promoters, polyadenylation

Supporting evidence

  • TAL cell populations uniquely express distinct Slc12a1 NKCC2 isoforms
  • Atlas reveals de novo Top1mt promoters in podocytes and sperm

Abstract

Alternative splicing creates cellular and phenotypic diversity; thus, characterizing splicing patterns across diverse cell types is essential for a comprehensive understanding of these cell types. However, existing full-length single-cell RNA-sequencing methods suffer from multiple technical limitations, such as the pervasive presence of reverse transcription artifacts across genes. Here, we introduce Ouro-Seq, a novel single-cell long-read sequencing framework with a versatile artifact removal mechanism for characterizing full-length mRNA species expressed by individual cells. We also developed a computational pipeline that identifies genuine full-length cDNAs and normalizes full-length mRNA size distributions for integration. Using Ouro-Seq, we constructed the Mouse Single-Cell Long-Read Splicing Atlas by collecting full-length transcriptomes of 103,304 nuclei or cells from 12 major organs and tissues of adult mice. Our atlas comprehensively characterizes alternative splicing, alternative promoter usage, and alternative polyadenylation events across cell types, revealing previously unappreciated functional heterogeneity among individual cells. Different cell types exhibit largely distinct expression patterns of various isoforms, corresponding to their specific morphologies and biological functions. Our splicing atlas and generalized long-read frameworks will empower researchers to fully interpret biological variation across full-length transcriptomes of single cells.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?